文献速递流行病学与生物统计基础与转化研究

身体衰弱、遗传风险、中介生物标志物与自杀未遂风险:一项前瞻性队列研究

Physical frailty, genetic risk, mediating biomarkers, and risk of suicide attempt: A prospective cohort study.
PubMed 文献 · PLoS Med · 2026-04-06

该前瞻性队列研究纳入442,920名基线无自杀未遂的英国生物银行参与者,中位随访13.6年。研究发现衰弱前期和衰弱状态均与自杀未遂风险升高相关,且与高遗传风险存在相加交互作用,部分生物标志物可能部分解释该关联。

要点

  • 衰弱前期和衰弱状态与自杀未遂风险升高相关,衰弱者风险更高。
  • 衰弱与高遗传风险存在相加交互作用,最高风险见于衰弱且高遗传风险者。
  • 肝脏功能、代谢、免疫和炎症相关生物标志物可能部分解释该关联。

核心结论

  • 衰弱前期和衰弱状态与自杀未遂风险升高相关,尤其在高遗传风险个体中。
  • 将衰弱评估和管理纳入一级预防策略可能对自杀未遂预防有意义。

研究设计与样本

  • 前瞻性队列研究,纳入442,920名基线无自杀未遂的英国生物银行参与者。
  • 衰弱状态采用Fried五组分表型评估,遗传风险通过多基因风险评分评估。
  • 采用Cox比例风险模型、孟德尔随机化分析和中介分析。

主要发现

  • 中位随访13.6年,1,518名(0.3%)个体发生自杀未遂。
  • 与不衰弱者相比,衰弱前期者自杀未遂HR为1.61(95%CI 1.44-1.80;P<0.001),衰弱者为2.16(95%CI 1.78-2.61;P<0.001)。
  • 遗传预测的衰弱与自杀未遂正相关(OR=2.06,95%CI 1.21-3.52;P=0.008)。
  • 除低体力活动外,所有衰弱组分均与自杀未遂风险升高显著相关,HR范围1.16(95%CI 1.01-1.33;P=0.038)至1.62(95%CI 1.43-1.82;P<0.001)。
  • 衰弱与遗传风险存在相加交互作用,最高风险见于衰弱且高遗传风险者(HR=3.09,95%CI 2.30-4.17;P<0.001),未检测到显著相乘交互作用。

临床怎么用

  • 在初级预防中考虑纳入衰弱评估和管理,可能有助于自杀未遂预防。
  • 对衰弱个体,尤其合并高遗传风险者,应关注自杀未遂风险。

局限性

  • 可能存在残余混杂因素。
  • 研究人群代表性有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: While physical frailty is linked to psychiatric disorders, its association with suicide attempt (SA) risk is unclear. We aimed to investigate the prospective association of physical frailty with SA risk and the modifying and potential mediating roles of genetic risk and blood biomarkers. METHODS AND FINDINGS: This cohort study included 442,920 UK Biobank participants free of SA at baseline. SA events were extracted by linking hospital inpatient records. Physical frailty status was assessed using the five-component Fried phenotype and categorized as nonfrail, prefrail, or frail. Genetic risk for SA was estimated through polygenic risk scores and categorized into high, intermediate, and low risk levels. Cox proportional hazard models were conducted to calculate the hazard ratios (HRs) and 95% confidence intervals (CIs) for the association. Mendelian randomization (MR) analyses were utilized to examine the association between genetically determined physical frailty and SA. Mediation analyses were performed to explore potential biological pathways involving circulating biomarkers. During a median follow-up of 13.6 years, 1,518 (0.3%) individuals developed SA. After multivariable adjustment for sociodemographic characteristics, genetic risk, lifestyle factors, psychiatric disorders, cardiovascular diseases, and cancer, the HRs for SA among those with pre-frailty were 1.61 (95% CI [1.44, 1.80]; P < 0.001) and frailty were 2.16 (95% CI [1.78, 2.61]; P < 0.001) compared with nonfrail individuals. Genetically predicted frailty was also positively associated with SA (odds ratio = 2.06, 95% CI [1.21, 3.52]; P = 0.008). Except for low physical activity, all frailty components were significantly associated with an increased risk of SA (all P < 0.05), with HRs ranging from 1.16 (95% CI [1.01, 1.33]; P = 0.038) to 1.62 (95% CI [1.43, 1.82]; P < 0.001). The additive interaction of physical frailty and genetic risk increased the risk of SA, with the highest risk observed among frail individuals with high genetic risk (HR = 3.09, 95% CI [2.30, 4.17]; P < 0.001), whereas no significant multiplicative interactions were detected. Biomarkers related to liver function, metabolism, immunity, and inflammation may have partially explained this association, accounting for a collective 14.15% (95% CI: 8.94%, 19.74%; P < 0.001) of the total effect, although MR analyses did not support causal mediating effects. The key limitations of this analysis include potential residual confounders and the limited representativeness of the study population. CONCLUSIONS: Pre-frail and frail states were associated with an increased risk of SA, especially among individuals with high genetic risk. Incorporating frailty assessment and management into primary prevention strategies may have implications for SA prevention.

来源:PLoS Med,查看原文。版权归原作者所有。

引用

  1. Hu W, Gao LJ, Liu TS, et al. Physical frailty, genetic risk, mediating biomarkers, and risk of suicide attempt: A prospective cohort study. PLoS Med. 2026. PMID: 41941430. doi:10.1371/journal.pmed.1005045

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。